Workiva Appoints Deepak Bharadwaj as EVP & Chief Product Officer to Fuel AI-Powered Platform Innovation — Neutral
WK Business Wire — December 01, 2025NEW YORK--(BUSINESS WIRE)--Workiva Inc. (NYSE:WK), a leading, AI-powered platform for transparency, accountability, and trust, today announced the appointment of Deepak Bharadwaj as EVP & Chief Product Officer. In his role, Bharadwaj will lead Workiva's product and UX organizations, driving the strategy and execution for the company's AI-powered platform and expanding product portfolio. “Deepak is a proven leader with deep experience in scaling high-growth Enterprise SaaS platforms,” said J.
Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE — Neutral
APUS Business Wire — December 01, 2025MATAWAN, N.J.--(BUSINESS WIRE)--(NYSE American: APUS) Apimeds Pharmaceuticals US, Inc. (“Apimeds”), a clinical-stage biotechnology company that completed its IPO in May 2025, today announced that it has merged with MindWave Innovations Inc (“MindWave”; the transaction, the “Merger”). Today, Apimeds and MindWave signed the merger agreement (the “Merger Agreement”) outlining the terms of the Merger, thus paving the way for a dual-growth enterprise spanning advanced biotechnology and institutional.
Medicus Pharma names president Carolyn Bonner as new CFO — Neutral
MDCX Proactive Investors — December 01, 2025Medicus Pharma (NASDAQ:MDCX) announced that Carolyn Bonner, who currently serving as the company's president, has been appointed to the role of chief financial officer (CFO). Bonner has been acting CFO since September 12, filling the role during the medical leave of former finance chief Jim Quinlan, who has now resigned from the company for health reasons.
JLL appoints Amanda Brimmer as CFO, Leasing Advisory and Head of Corporate Development — Neutral
JLL PRNewsWire — December 01, 2025Brimmer will drive financial performance for the Leasing Advisory business and lead strategic growth initiatives for the firm CHICAGO , Dec. 1, 2025 /PRNewswire/ -- JLL announced the appointment of Amanda Brimmer as CFO, Leasing Advisory and Head of Corporate Development. Reporting to JLL CFO Kelly Howe, Brimmer will partner with business leaders globally to drive financial growth and performance.
Accenture ties up with OpenAI to equip thousands of its employees with ChatGPT — Positive
ACN Reuters — December 01, 2025Accenture will equip tens of thousands of its IT professionals with ChatGPT Enterprise through a partnership with OpenAI, as the consulting firm looks to capitalize on the growing demand for AI services.
Berkshire's Alphabet Bet Has Done Magnificently—Is it Too Late to Follow? — Neutral
GOOG GOOGL 24/7 Wall Street — December 01, 2025In case you missed it, it was revealed that Warren Buffett's legendary conglomerate Berkshire Hathaway (NYSE:BRK-B) punched its ticket to Alphabet (NASDAQ:GOOG) last quarter.
Wall Street is Still Pounding the Table Over Nvidia, Alphabet and Wynn — Positive
GOOG GOOGL NVDA WYNN 24/7 Wall Street — December 01, 2025Analysts at Morgan Stanley just reiterated an overweight rating on Nvidia with a $250 price target. Analysts at Guggenheim says Alphabet could run even higher. The firm raised its price target on GOOG to $375 from $330 with a buy rating.
7,200-7,300 likely for the S&P 500 in December, says Fundstrat's Tom Lee — Positive
IVV SPLG SPXL SPY SSO UPRO VOO CNBC Television — December 01, 2025Fundstrat Capital CIO Tom Lee told CNBC on Monday that he thinks the S&P 500 is likely to reach 7,200 or 7,300 in December, after setting very aggressive year-end targets for the index and bitcoin earlier this year.
NanoViricides inks regulatory services deal to advance orphan drug strategy for antiviral NV-387 — Positive
NNVC Proactive Investors — December 01, 2025NanoViricides (NYSE-A:NNVC) said on Monday it signed a master services agreement with regulatory consulting firm Only Orphans Cote LLC to support the company's orphan drug strategy for its broad-spectrum antiviral candidate NV-387. The firm, founded by former US Food and Drug Administration official Dr Timothy Cote, will help develop and prosecute orphan drug designation applications for NV-387 at the FDA's Office of Orphan Products, NanoViricides said.
You missed the boat on Broadcom. You watched it morph from a boring chipmaker into a trillion-dollar "AI Landlord.
(all amounts are in U.S. dollars except where otherwise indicated) MONTREAL, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL: TSX and NYSE) (“Gildan” or the “Company”) announced today that it has completed the previously announced acquisition of HanesBrands Inc. (“HanesBrands”), creating a global apparel leader. “Today marks the beginning of an exciting new chapter.
SAN FRANCISCO--(BUSINESS WIRE)--Elastic (NYSE: ESTC), the Search AI Company, announced today that it has achieved the Amazon Web Services (AWS) Agentic AI Specialization, a new category launched within the AWS AI Competency. This specialization recognizes Elastic as an AWS Partner that enables customers to deploy smart, self-operating AI systems that can process, plan, and work independently to execute complex business processes. The AWS AI Specialization in Agentic AI distinguishes Elastic as.
Kodiak Gas Services Announces Pricing of Offering of Common Stock by Selling Stockholder — Neutral
KGS Business Wire — December 01, 2025THE WOODLANDS, Texas--(BUSINESS WIRE)--Kodiak Gas Services, Inc. (NYSE: KGS) (“Kodiak” or the “Company”) today announced the pricing of an underwritten offering (the “Offering”) of 9,762,573 shares of its common stock by Frontier TopCo Partnership, L.P. (the “Selling Stockholder”), an affiliate of the funds known as EQT Infrastructure III and EQT Infrastructure IV, at a price to the public of $34.60 per share. Kodiak will not sell any shares of its common stock in the Offering and will not rece.
Nasdaq, Inc. Announces Cash Tender Offers for Up to $95 Million Aggregate Purchase Price of Outstanding Debt Securities — Neutral
NDAQ GlobeNewsWire — December 01, 2025NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) (“Nasdaq” or the “Company”) today announced its offers to purchase for cash in the order of priority set forth in the table below (the “Acceptance Priority Levels”) up to an aggregate purchase price of $95,000,000 (excluding Accrued Interest (as defined below)) (the “Maximum Tender Payment”) for its outstanding Notes, subject to (i) a sub-cap of $80,000,000 in aggregate principal amount (the “2028 Notes Cap”) of the Company's 5.350% Senior Notes due 2028 (the “2028 Notes”) and (ii) a sub-cap of $10,000,000 in aggregate principal amount (the “2052 Notes …
The S&P 500 Rises With December 2025 Rate Cut Expectations — Positive
IVV SPLG SPXL SPY SSO UPRO VOO Seeking Alpha — December 01, 2025On Thanksgiving holiday week, the S&P 500 rose 1.7% from its previous week's close, reaching 6,849.09 by the close of trading on Friday, 28 November 2025. In 2026, the FedWatch tool gives better than even odds for additional quarter-point rate cuts on 29 April (2026-Q2), 29 July (2026-Q3), and 9 December (2026-Q4), which is unchanged from the previous week.
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors — Neutral
MAIA GlobeNewsWire — December 01, 2025CHICAGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that the CEO and certain members of the Company's Board of Directors purchased approximately 182,445 shares of MAIA common stock at market price between November 21 and 28, 2025. The average common stock price was $1.06.
CrowdStrike (CRWD) reports earnings on Tuesday after the closing bell, and Rick Ducat offers his technical insight into key levels to watch ahead of the cybersecurity firm's report. Tom White also takes investors through the options front with an example trade.
The latest Walmart Inc. (NYSE: WMT) earnings show it is still the dominant retailer in America.